Tenon Medical, Inc. Stock

Equities

TNON

US88066N2045

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 03:12:47 2024-05-28 pm EDT 5-day change 1st Jan Change
0.7201 USD -3.11% Intraday chart for Tenon Medical, Inc. -4.87% -54.42%
Sales 2024 * 4.42M Sales 2025 * 8.97M Capitalization 2.77M
Net income 2024 * -15M Net income 2025 * -13M EV / Sales 2024 * 0.03 x
Net cash position 2024 * 2.63M Net cash position 2025 * 5.56M EV / Sales 2025 * -0.31 x
P/E ratio 2024 *
-0.21 x
P/E ratio 2025 *
-0.57 x
Employees 21
Yield 2024 *
-
Yield 2025 *
-
Free-Float 89.5%
More Fundamentals * Assessed data
Dynamic Chart
Tenon Medical, Inc. Announces the Retirement of Steven Van Dick as Executive Vice President, Finance and Administration, and Assistant Secretary Effective as of July 31, 2024 CI
Tenon Medical, Inc. Announces the Retirement of Steven Van Dick as Chief Financial Officer effective as of July 31, 2024 CI
Transcript : Tenon Medical, Inc., Q1 2024 Earnings Call, May 14, 2024
Benchmark Cuts Tenon Medical's Price Target to $3 From $5, Maintains Speculative Buy Rating MT
Tenon Medical, Inc. Appoints Kristine Jacques as Independent Member of the Board of Directors CI
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Ahead of Key Economic Data MT
Transcript : Tenon Medical, Inc., Q4 2023 Earnings Call, Mar 12, 2024
Tenon Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tenon Medical, Inc. announced that it has received $2.605115 million in funding CI
Tenon Medical, Inc. Announces Resignation of Frank Fischer as Member of Board of Directors, Audit Committee and Chairman of the Compensation Committee CI
Tenon Medical, Inc. announced that it has received $1.25 million in funding CI
Tenon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Tenon Medical, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Earnings Flash (TNON) TENON MEDICAL Reports Q3 Revenue $944,000 MT
Tenon Medical Shares Rise 42% After Passing FDA Inspection DJ
More news
1 day-3.11%
1 week-4.87%
Current month-4.62%
1 month-4.19%
3 months-42.39%
6 months-62.30%
Current year-54.42%
More quotes
1 week
0.70
Extreme 0.7
0.75
1 month
0.70
Extreme 0.7
0.98
Current year
0.70
Extreme 0.7
1.72
1 year
0.70
Extreme 0.7
13.70
3 years
0.70
Extreme 0.7
598.90
5 years
0.70
Extreme 0.7
598.90
10 years
0.70
Extreme 0.7
598.90
More quotes
Managers TitleAgeSince
Founder 58 12-06-18
Chief Executive Officer 56 -
Director of Finance/CFO 69 21-05-31
Members of the board TitleAgeSince
Founder 70 20-11-30
Director/Board Member 64 21-12-31
Director/Board Member 81 21-12-31
More insiders
Date Price Change Volume
24-05-28 0.7201 -3.11% 28,610
24-05-24 0.7432 -0.68% 6,375
24-05-23 0.7483 -0.02% 21,680
24-05-22 0.7484 -1.13% 8,914
24-05-21 0.757 -5.36% 36,869

Delayed Quote Nasdaq, May 28, 2024 at 03:12 pm EDT

More quotes
Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The Company has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7201 USD
Average target price
3.5 USD
Spread / Average Target
+386.04%
Consensus